Usana Health Sciences R&D Spending Growth & History (USNA)
Usana Health Sciences's r&d spending was $10.7M for fiscal 2025.
View full Usana Health Sciences company overviewUsana Health Sciences annual r&d spending history
| Fiscal year | Period ended | R&D spending | Change | Growth |
|---|---|---|---|---|
| 2025 | 2026-01-03 | $10.7M | −$878,000 | −7.59% |
| 2024 | 2024-12-28 | $11.6M | $125,000 | +1.09% |
| 2023 | 2023-12-30 | $11.4M | −$117,000 | −1.01% |
| 2022 | 2022-12-31 | $11.6M | $451,000 | +4.06% |
| 2021 | 2022-01-01 | $11.1M | $479,000 | +4.50% |
| 2020 | 2021-01-02 | $10.6M | $374,000 | +3.65% |
| 2019 | 2019-12-28 | $10.3M | $17,000 | +0.17% |
| 2018 | 2018-12-29 | $10.2M | $1.3M | +14.41% |
| 2017 | 2017-12-30 | $9.0M | $110,000 | +1.24% |
| 2016 | 2016-12-31 | $8.8M | $2.4M | +37.73% |
| 2015 | 2016-01-02 | $6.4M | $1.3M | +25.20% |
| 2014 | 2015-01-03 | $5.1M | $45,000 | +0.89% |
| 2013 | 2013-12-28 | $5.1M | $419,000 | +8.98% |
| 2012 | 2012-12-29 | $4.7M | $593,000 | +14.57% |
| 2011 | 2011-12-31 | $4.1M | $229,000 | +5.96% |
| 2010 | 2011-01-01 | $3.8M | — | — |
Usana Health Sciences r&d spending trends
Over the last five fiscal years, Usana Health Sciences's r&d spending increased from $10.6M to $10.7M, a change of $60,000.
What research and development spending means
Research and development (R&D) spending covers the costs of creating and improving products, services, software, technologies, and processes. Higher R&D spending may support future innovation, but the amount alone does not show whether those investments will generate returns.
SEC-reported R&D expense
TickerStat standardizes research and development expense reported in company SEC filings, including the software-specific US-GAAP R&D concept when it is the filer’s primary R&D expense line. It is historical company-reported spending, not an estimate or forecast. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Usana Health Sciences source filings ↗